Increased risk of psoriasiform diseases with anti-TNF agents

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-48102-3
中图分类号
学科分类号
摘要
引用
收藏
页码:9 / 9
相关论文
共 50 条
  • [2] Infection risk in RA patients on anti-TNF agents
    Breen, P
    Gerbino, AJ
    Barnes, R
    Hillson, JL
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 298 - 299
  • [4] Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease
    Lauren A. George
    Akash Gadani
    Raymond K. Cross
    Guruprasad Jambaulikar
    Leyla J. Ghazi
    Digestive Diseases and Sciences, 2015, 60 : 3424 - 3430
  • [5] Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease
    George, Lauren A.
    Gadani, Akash
    Cross, Raymond K.
    Jambaulikar, Guruprasad
    Ghazi, Leyla J.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (11) : 3424 - 3430
  • [6] Hepatotoxicity of Anti-TNF Agents
    Maurizio Bonacini
    Marwan Ghabril
    Herbert L. Bonkovsky
    Digestive Diseases and Sciences, 2014, 59 : 1070 - 1071
  • [7] Hepatotoxicity of Anti-TNF Agents
    Bonacini, Maurizio
    Ghabril, Marwan
    Bonkovsky, Herbert L.
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (05) : 1070 - 1071
  • [8] Risk of lymphoma in patients with RA treated with anti-TNFα agents
    Franklin, JP
    Symmons, DPM
    Silman, AJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) : 657 - 658
  • [9] Clinical use of anti-TNF therapy and increased risk of infections
    Ali, Tauseef
    Kaitha, Sindhu
    Mahmood, Sultan
    Ftesi, Abdul
    Stone, Jordan
    Bronze, Michael S.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2013, 5 : 79 - 99
  • [10] INCREASED RISK OF ANTI-DRUG ANTIBODIES TO A SECOND ANTI-TNF IN PATIENTS WHO DEVELOPED ANTIBODIES TO THE FIRST ANTI-TNF
    Yanai, Henit A.
    Amir, Shira
    Avni-Biron, Irit
    Perets, Tsachi Tsadok
    Shamir, Raanan
    Dotan, Iris
    Assa, Amit
    GASTROENTEROLOGY, 2020, 158 (06) : S671 - S671